Outcomes of Unfit Patients With CLL Included in the GIMEMA LLC1114 Trial Who Discontinued Ibrutinib Due to Reasons Other Than Disease Progression
Clinical trial NCT06084923 · UNKNOWN
Trial details
- NCT number
- NCT06084923
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2024-05-01
- Primary completion
- 2026-05-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.